Cargando…
Engaging study participants in interpreting results: lessons from the TRIO study in Kenya and South Africa
Background: Women account for 56% of new HIV infections in sub-Saharan Africa. Multipurpose Prevention Technologies (MPTs) are promising interventions because they combine HIV prevention with a less stigmatizing indication, such as pregnancy. We conducted a study with three placebo-only MPT products...
Autores principales: | Agot, Kawango, Minnis, Alexandra M, Manenzhe, Kgahlisho, Browne, Erica N, Ahmed, Khatija, Okello, Timothy, van der Straten, Ariane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636186/ https://www.ncbi.nlm.nih.gov/pubmed/31372060 http://dx.doi.org/10.2147/IJWH.S193905 |
Ejemplares similares
-
The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention
por: van der Straten, Ariane, et al.
Publicado: (2018) -
“We are not the same”: African women’s view of multipurpose prevention products in the TRIO clinical study
por: Shapley-Quinn, Mary Kate, et al.
Publicado: (2019) -
Young Women’s Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa
por: Minnis, Alexandra M., et al.
Publicado: (2018) -
End-Users’ Product Preference Across Three Multipurpose Prevention Technology Delivery Forms: Baseline Results from Young Women in Kenya and South Africa
por: Weinrib, Rachel, et al.
Publicado: (2017) -
Female and male partner perspectives on placebo Multipurpose Prevention Technologies (MPTs) used by women in the TRIO study in South Africa and Kenya
por: Wagner, Laura Danielle, et al.
Publicado: (2022)